Skip to main content
Back to HSG

HSG's Life Science Portfolio

Browse 3 Life Science companies funded by HSG. See funding amounts, founder contacts, and investment details.

Life Science Companies
3
Total Funding in Life Science
$138.0M

Life Science Portfolio Companies (3)

Export
BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore HSG's Full Portfolio

View all companies funded by HSG across every industry and funding stage.

View Full HSG Portfolio